The 20 Best Squamous Cell Skin Carcinoma Doctors Near Me in Towson, MD

Dr. Elise Ng is as assistant professor of dermatology and the Director of Dermatologic Surgery in the Department of Dermatology at Johns Hopkins. She oversees the Johns Hopkins team of Mohs surgeons across four clinical sites, including the Johns Hopkins Outpatient Center, Greenspring Station, the Medical Pavilion at Howard County, and Sibley Memorial Hospital. She also serves as the Director of the Johns Hopkins Micrographic Surgery and Dermatologic Oncology Fellowship training program and is the clinical co-director of the Melanoma Program at the Sidney Kimmel Comprehensive Cancer Center. Her areas of clinical expertise include Mohs micrographic surgery, complex facial reconstruction following skin cancer surgery, melanoma, cosmetic scar revision, and surgical management of benign and malignant skin lesions. Dr. Ng graduated magna cum laude from Harvard College and was awarded the Harvard College Scholar Award for academic excellence. She received her medical degree from Columbia University College of Physicians and Surgeons and subsequently trained at New York University School of Medicine, one of the nation's top dermatology programs, where she was selected to be chief resident. Following residency, she completed a prestigious fellowship in Mohs micrographic surgery and dermatologic oncology with a focus on advanced reconstruction under the tutelage of one of the leaders in the field at Mount Sinai Hospital in New York. She serves as a reviewer for and her research has been published in premier peer-reviewed journals including Journal of the American Academy of Dermatology and Dermatologic Surgery. Dr. Ng joined the faculty of Johns Hopkins School of Medicine in 2017 and has been consistently recognized as a “Top Doctor” by Baltimore Magazine. Dr. Ng is rated as an Advanced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, Melanoma, and Bowen's Disease. Dr. Ng is board certified in American Board Of Dermatology.

Dr. Lipson is an internationally-recognized skin cancer and immunotherapy specialist at Johns Hopkins. He received his medical degree in 2005 from the Mount Sinai School of Medicine in New York City, where he graduated with distinction in research. He completed his internship and residency in Internal Medicine at The Johns Hopkins Hospital, and completed a Medical Oncology fellowship at the Johns Hopkins Kimmel Cancer Center. Dr. Lipson leads cutting edge clinical trials for patients with melanoma and other skin cancers. As a member of the Johns Hopkins Melanoma and Cancer Immunology Programs, he focuses on evaluating novel therapies for patients with high-risk or advanced disease. Dr. Lipson’s publications include the first reports of organ transplant recipients treated with immune checkpoint inhibitors for advanced cancer, and the first description of kidney retransplantation performed after immunotherapy–related organ rejection. Based on his published work, Dr. Lipson initiated a clinical trial testing a novel combination of immune-based therapies for kidney transplant recipients with advanced selected cancers. Results from this trial - the first of its kind - were reported in 2022 at an international oncology meeting. Dr. Lipson is a leader in the clinical development of relatlimab, an antibody blocking the LAG-3 immune checkpoint. He leads a phase 2 trial testing combination immune checkpoint inhibitor therapy—including anti-LAG-3—for patients with advanced basal cell carcinoma. In June 2021, Dr. Lipson presented findings from the first phase 3 study establishing the LAG-3 pathway as the third immune checkpoint pathway in history, after CTLA-4 and PD-1, for which blockade has clinical benefit. This trial supported the FDA's approval of a new therapy for patients with advanced melanoma. In addition to his research activities, Dr. Lipson is an educator in the field of cancer immunotherapy. Many of his lectures focus on the management of immune-mediated drug toxicities associated with novel cancer drugs. Dr. Lipson conducts regular clinical practices in Baltimore, Maryland and at Sibley Memorial Hospital in Washington, D.C. as part of the multidisciplinary Melanoma Program at Johns Hopkins. Dr. Lipson is rated as a Distinguished provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Metastatic Uveal Melanoma, Melanoma of the Eye, and Pancreaticoduodenectomy. Dr. Lipson is board certified in American Board Of Internal Medicine.

Stanley Miller is a Dermatologist practicing medicine in Towson, Maryland. Dr. Miller is rated as an Advanced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, Bowen's Disease, and Head and Neck Squamous Cell Carcinoma (HNSCC).

Rachel Schleichert is a Dermatologist practicing medicine in Towson, Maryland. Dr. Schleichert is rated as an Advanced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, Bowen's Disease, and Pompholyx Eczema.

Dr. Carole Fakhry is a head and neck surgical oncologist at Johns Hopkins and treats the breadth of patients with head and neck cancers, including cancers of the tonsils, base of tongue, mouth, larynx, thyroid, salivary gland (parotid, submandibular gland) and skin cancers among others. She is the Chief of the Division of Head and Neck Surgery and Director of the Head and Neck Cancer Center. She also serves as director of the head and neck group in the Bloomberg~Kimmel Institute for Cancer Immunotherapy and the head and neck surgical oncology fellowship. She is the associate editor for Oral Oncology and serves on several editorial boards. After an undergraduate degree at Stanford University, she completed medical school, residency in otolaryngology head and neck surgery, and a fellowship in head and neck surgical oncology at Johns Hopkins. She has also received a master’s in public health from the Johns Hopkins Bloomberg School of Public Health. She is presently a professor in the Johns Hopkins Department of Otolaryngology-Head and Neck Surgery, Oncology, and Johns Hopkins Bloomberg School of Public Health Department of Epidemiology. Her research interest focuses on the role of human papillomavirus (HPV) in head and neck squamous cell cancer. She has demonstrated that the presence of HPV confers a prognostic advantage to individuals with oropharyngeal cancer and that HPV is associated with unique clinical characteristics. In addition to the clinical implications of HPV in head and neck cancer, she is co-principal investigator of a large study to understand screening individuals at “high risk” of malignancy and evaluating imaging modalities to improve diagnostics and early detection of HPV- related head and neck cancer. Dr. Fakhry is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Human Papillomavirus Infection, Head and Neck Squamous Cell Carcinoma (HNSCC), Salivary Gland Tumors, Laryngectomy, and Gastrostomy. Dr. Fakhry is board certified in Head And Neck Surgery.

Dr. William H. Sharfman is an associate professor of oncology and dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include cutaneous oncology, dermatology and immunotherapy. He helped create the well-established Melanoma Program at the Johns Hopkins Kimmel Cancer Center in 1994. Dr. Sharfman serves as the director of cutaneous oncology and clinical co-director for oncology at the Johns Hopkins Melanoma Program. He earned his M.D. from the University of Toledo College of Medicine. He completed his residency at Cleveland Clinic and performed a fellowship in hematology and oncology at Cleveland Clinic. Dr. Sharfman's research interests include novel therapies for high risk and advanced melanoma patients. Dr. Sharfman is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Eccrine Porocarcinoma, and Familial Pancreatic Cancer. Dr. Sharfman is board certified in American Board Of Internal Medicine.

Diane Orlinsky is a Dermatologist practicing medicine in Towson, Maryland. Dr. Orlinsky is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Syringoma, Syringocystadenoma Papilliferum, Sebaceous Adenoma, and Trichoepithelioma.

Bonnie Epstein is a Dermatologist practicing medicine in Lutherville Timonium, Maryland. Dr. Epstein is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Neurocutaneous Melanosis, Giant Congenital Nevus, Familial Atypical Multiple Mole Melanoma Syndrome, and Giant Congenital Melanocytic Nevus.

Linda Wang is a Dermatologist practicing medicine in Lutherville Timonium, Maryland. Dr. Wang is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Telangiectasia, Spider Angioma, Intertrigo, and Rosacea.

Ciro Martins is a Dermatologist practicing medicine in Baltimore, Maryland. Dr. Martins is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Epidural Lipomatosis, Actinic Keratosis, Psoriasis, and Intertrigo.

Regina Anderson is an Internal Medicine provider practicing medicine in Baltimore, Maryland. Dr. Anderson is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Actinic Keratosis, Warts, Basal Cell Skin Cancer, and Squamous Cell Skin Carcinoma.

Paul Ringelman is a Plastic Surgeon practicing medicine in Towson, Maryland. Dr. Ringelman is rated as an Advanced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Epidural Lipomatosis, Melanoma, Basal Cell Skin Cancer, and Squamous Cell Skin Carcinoma.

Zain Syed is a Dermatologist practicing medicine in Lutherville, Maryland. Dr. Syed is rated as an Advanced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, Bowen's Disease, Head and Neck Squamous Cell Carcinoma (HNSCC), and Fasciotomy.

Howard Robinson is a Dermatologist practicing medicine in Lutherville, Maryland. Dr. Robinson is rated as an Advanced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. He is also highly rated in 50 other conditions, according to our data. His clinical expertise encompasses Neurocutaneous Melanosis, Giant Congenital Nevus, Giant Congenital Melanocytic Nevus, and Familial Atypical Multiple Mole Melanoma Syndrome.

Amita Bagal is an Oral and Maxillofacial Surgeon practicing medicine in Lutherville Timonium, Maryland. Dr. Bagal is rated as an Advanced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, Ear Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC).

Dr. Ronald Sweren is an assistant professor of dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include cutaneous lymphoma/mycosis fungoides, phototherapy/ photopheresis and melanoma. Dr. Sweren also serves as director of the Phototherapy/Photopheresis Program in the Department of Dermatology. Dr. Sweren earned his M.D. from the University of Maryland School of Medicine. He completed his residency in dermatology at University of Maryland Medical Center and in pediatrics at Sinai Hospital of Baltimore. Dr. Sweren is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Mycosis Fungoides, Cutaneous T-Cell Lymphoma (CTCL), Melanoma, and T-Cell Lymphoma. Dr. Sweren is board certified in American Board Of Dermatology and American Board Of Pediatrics.

Dr. Sewon Kang is the Noxell Professor and Chairman of the Department of Dermatology at the Johns Hopkins University School of Medicine and the Dermatologist-in-Chief of Johns Hopkins Hospital. He is also founder and co-Director of the Cutaneous Translational Research Program (CTReP) at Hopkins. A recipient of the Dermatology Foundation's Career Development Award, he has received other research awards and grants from the American Dermatological Association, the National Psoriasis Foundation and the National Institutes of Health (Roadmap T32, K24, and R01). His research focus has been in the areas of skin pharmacology and photomedicine. He is the Past President of the Photomedicine Society, and the American Acne and Rosacea Society. Dr. Kang is or has been on the Board of Directors of multiple organizations including, the Society for Investigative Dermatology, the Association of Professors of Dermatology, the Dermatology Foundation, and the Skin of Color Society. An author on over 240 publications and book chapters, Dr. Kang is also the Editor-in-Chief of the 9th edition of the Fitzpatrick's Dermatology textbook. He is an inventor/co-inventor of 17 patents and has given over 300 presentations globally. A graduate with honors from Williams College and the University of Michigan, Dr. Kang completed dermatology residency and fellowship at the Harvard Medical School/Massachusetts General Hospital. He sees patients exclusively at the Johns Hopkins Hospital, and his areas of clinical expertise include photomedicine, skin cancer (melanoma), skin aging, and dermatology for ethnic skin. Dr. Kang is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Acne, Melanoma, Prurigo Nodularis, and Rosacea. Dr. Kang is board certified in American Board Of Dermatology.

Daniel Synkowski is a Dermatologist practicing medicine in Lutherville, Maryland. Dr. Synkowski is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Hidradenitis Suppurativa, Melanoma, Actinic Keratosis, and Warts. Dr. Synkowski is board certified in American Board Of Dermatology.

Dr. Tanguy Seiwert is an oncologist in Baltimore, caring for patients with head and neck cancer. He serves as the director of the Head and Neck Cancer Oncology Disease Program and the co-director of the Bloomberg~Kimmel Institute for Immunotherapy at the Head and Neck Cancer Program at the Johns Hopkins School of Medicine. Dr. Seiwert earned his M.D. at Johannes Gutenberg Universität in Mainz, Germany. He completed his residency at the Duke University School of Medicine and performed a fellowship in hematology/oncology at the University of Chicago Medicine Mitchell Hospital-Hyde Park. Dr. Seiwert joined the Johns Hopkins faculty in 2019. Prior to joining Johns Hopkins, Dr. Seiwert was director of the Head and Neck Cancer Program at the University of Chicago. Dr. Seiwert’s research interests include immunologic and genomic profiling. He has given numerous invited talks on head and neck cancer both nationally and internationally. Dr. Seiwert served as chief editor for Frontiers in Head and Neck Cancer and as an editorial board member for the Journal of Clinical Oncology and Oral Oncology. He is a reviewer for multiple medical journals, including Lancet Oncology, Annals of Oncology and Clinical Cancer Research. He has been recognized by the American Association for Clinical Oncology for multiple Merit Awards and a Young Investigator Award. He was a member of the NCI Head and Neck Cancer Steering Committee, and is a member of the American Association for Clinical Oncology, the Society for Immunotherapy of Cancer, and the European Society of Clinical Oncology. Dr. Seiwert is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Glioma, Laryngeal Cancer, Tongue Cancer, Oral Squamous Cell Carcinoma, and Gastrostomy. Dr. Seiwert is board certified in American Board Of Internal Medicine.

Manisha Loss is a Dermatologist practicing medicine in Baltimore, Maryland. Dr. Loss is rated as an Advanced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Melanoma, Multiple Familial Trichoepithelioma, Trichoepithelioma, and Actinic Keratosis.